Yeah it will tackle the most prevalent cancers, like breast and prostate cancer, but be unable to be developed for cancers like brain cancer, since it is a radio pharmaceutical.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11103494/

You can read more about it here. It is making very good progress, multiple companies are starting to make manufactured levels of the drug, and results are very good. Again, I highly doubt poor people will have access to it.